Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice
The single greatest safety risk is not the compound itself but unverified sourcing: contamination, mislabeling, and inconsistent purity in the research peptide market make clinical supervision and verified supply chains non-negotiable
~ AlphaMD Testosterone replacement therapy (TRT) can be life-changing for individuals experiencing low testosterone levels
Modifier 59 and CPT 96372: When and How to Use It Modifier 59 signals a "Distinct Procedural Service." Use it with 96372 when a second or subsequent injection is given at the same visit, involving a different drug administered at a different anatomical site
Symptoms can include: Muscle weakness or cramping Irregular heartbeat Unusual tiredness
Stress management similarly affects outcomes